Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents
This study has been completed.
Sponsor:
GlaxoSmithKline
Collaborator:
Aeras
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00950612
First received: July 23, 2009
Last updated: June 23, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2010 |
| Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | December 24, 2010 |